These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 397029)

  • 21. [Results of the use of trimebutine in abdominal surgery].
    Stoppa R; Petit J
    J Sci Med Lille; 1972; 90(8):319-20. PubMed ID: 4643055
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical use of prifinium bromide: a new spasmolytic agent].
    Marini U; Spotti D; Visconti P
    Clin Ter; 1978 Nov; 87(4):367-74. PubMed ID: 36254
    [No Abstract]   [Full Text] [Related]  

  • 23. Cimetropium bromide, a new antispasmodic compound: pharmacology and therapeutic perspectives.
    Scarpignato C; Bianchi Porro G
    Int J Clin Pharmacol Res; 1985; 5(6):467-77. PubMed ID: 3912339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical trial of the use of a drug combination in gastroenterology].
    Nizzo MC; Mavilio R; Lepore R
    Clin Ter; 1978 Mar; 84(5):491-500. PubMed ID: 348384
    [No Abstract]   [Full Text] [Related]  

  • 25. [Proglumide in peptic ulcer and in gastroduodenal pathology. Clinical, biological and endoscopic study].
    Bennani A
    Med Chir Dig; 1979; 8(4):351-6. PubMed ID: 502629
    [No Abstract]   [Full Text] [Related]  

  • 26. [The effect of quaternary derivatives of scopolamine (cimetropium bromide) on intestinal motility].
    Sagrada A; Schiavone A; Cervo L; Giachetti A
    Boll Chim Farm; 1986 Feb; 125(2):75-9. PubMed ID: 3741647
    [No Abstract]   [Full Text] [Related]  

  • 27. [Controlled clinical studies of the action of a drug combination in the pathology of the upper digestive tract].
    Crespi M; Casale G; Casale V; Grassi A; Conti E
    Minerva Dietol Gastroenterol; 1981; 27(4):599-610. PubMed ID: 7038545
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical evaluation of a new digestivo-spasmolytic agent].
    Glassman J; Odzak A
    Prensa Med Argent; 1966 Sep; 53(37):2033-5. PubMed ID: 5993479
    [No Abstract]   [Full Text] [Related]  

  • 29. [Phenicaberan in the complex therapy of patients with gastritis and gastroduodenitis in conjunction with bile duct diseases].
    Mokhun' IK; Vladkovskiĭ IK; Luk'ianchuk DG; Splavskiĭ OI
    Vrach Delo; 1987 Nov; (11):53-6. PubMed ID: 3439125
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical trial of a new synthetic anticholinergic: 1290 CERM].
    Herne N; Parneix Y
    Mars Med; 1969; 106(7):628-30. PubMed ID: 5399370
    [No Abstract]   [Full Text] [Related]  

  • 31. [Sodium diclofenac in the treatment of biliary pain: a controlled study using hyoscine N-butylbromide].
    Rossi PC; Giudicelli N; Parenti G; Pacetti E
    Clin Ter; 1988 Sep; 126(6):405-10. PubMed ID: 2974401
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy of trimebutine therapy in patients with gastroesophageal reflux disease and irritable bowel syndrome.
    Kountouras J; Chatzopoulos D; Zavos C; Boura P; Venizelos J; Kalis A
    Hepatogastroenterology; 2002; 49(43):193-7. PubMed ID: 11941952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical trials of a combination of an original gastric demulcent and a synthetic anticholinergic agent].
    Evreux M; Jenoudet L
    Lyon Med; 1972 Jun; 227(11):1181-4. PubMed ID: 4564809
    [No Abstract]   [Full Text] [Related]  

  • 34. [Quality of results obtained in digestive pathology by acting upon motor, secretory and hormonal phenomena at the same time].
    Darnis F; Streichenberger G
    Therapeutique; 1973 Dec; 49(10):721-4. PubMed ID: 4600237
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effects of the drug HSp-2986 on antral motility, pyloric opening and gastric distensibility. Study with the fibrogastrocamera].
    Espejo Romero H; Castillo Rosales T
    G E N; 1972; 27(1):1-12. PubMed ID: 4632023
    [No Abstract]   [Full Text] [Related]  

  • 36. [Trial of trimebutine in the recovery of digestive transit in abdominal surgery (apropos of 100 cases)].
    Malavaud A
    Anesth Analg (Paris); 1972; 29(1):65-9. PubMed ID: 5069154
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on papillary function and effect of prifinium bromide and other antispasmodics on motility of the papillary region (sphincter of Oddi) in humans.
    Kobayashi K; Mitani E; Tatsumi S; Sasaki Y; Nakamura M; Yamada H
    Clin Ther; 1985; 7(2):154-63. PubMed ID: 2859116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical evaluation of oxybutynin chloride.
    Hock CW
    Curr Ther Res Clin Exp; 1967 Aug; 9(8):437-40. PubMed ID: 4962468
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical experimentation in gastro-duodenal pathology with an anticholinergic, oxypyrronium bromide. Objective evaluation of its action on gastric secretion].
    Dureux JB; Rauber G; Regnier F; Ruff G
    Ann Med Nancy; 1965; 4():633-41. PubMed ID: 5839672
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of benzacine on the gallbladder motility in chronic cholecystitis].
    Skakun NP; Romanchak MN; Vazhinskiĭ VE
    Vrach Delo; 1969 Jul; 7():131-2. PubMed ID: 5380644
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.